Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Bioventus (BVS) Accumulated Depreciation & Amortization (2020 - 2025)

Bioventus' Accumulated Depreciation & Amortization history spans 6 years, with the latest figure at $5.7 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 25.16% year-over-year to $5.7 million; the TTM value through Dec 2025 reached $5.7 million, down 25.16%, while the annual FY2025 figure was $5.7 million, 25.16% down from the prior year.
  • Accumulated Depreciation & Amortization reached $5.7 million in Q4 2025 per BVS's latest filing, up from $1.4 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $9.7 million in Q4 2022 to a low of $1.4 million in Q3 2025.
  • Average Accumulated Depreciation & Amortization over 5 years is $4.3 million, with a median of $3.0 million recorded in 2025.
  • Peak YoY movement for Accumulated Depreciation & Amortization: soared 336.9% in 2022, then crashed 76.24% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $8.4 million in 2021, then grew by 16.56% to $9.7 million in 2022, then decreased by 9.29% to $8.8 million in 2023, then dropped by 13.46% to $7.7 million in 2024, then decreased by 25.16% to $5.7 million in 2025.
  • Per Business Quant, the three most recent readings for BVS's Accumulated Depreciation & Amortization are $5.7 million (Q4 2025), $1.4 million (Q3 2025), and $3.0 million (Q2 2025).